Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthern 2 Vct Regulatory News (NTV)

Share Price Information for Northern 2 Vct (NTV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.50
Bid: 53.00
Ask: 56.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.66%)
Open: 54.50
High: 54.50
Low: 54.50
Prev. Close: 54.50
NTV Live PriceLast checked at -
Northern 2 VCT is an Investment Trust

To invest mainly in unquoted venture capital holdings and aims to provide high long-term tax-free returns to shareholders through a combination of dividend yield and capital growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value

9 Feb 2024 08:00

Net Asset Value

9 FEBRUARY 2024

NORTHERN 2 VCT PLC

UNAUDITED NET ASSET VALUE AS AT 31 DECEMBER 2023

Northern 2 VCT PLC (“the Company”) is a Venture Capital Trust (“VCT”) launched in 1999 and managed by Mercia Fund Management Limited. The Company’s objective is to provide long-term tax-free returns to investors through a combination of dividend yield and capital growth, by investing in a portfolio of investments mainly comprising unquoted venture capital holdings. In order to maintain approval by HM Revenue & Customs as a VCT, the Company is required to comply on a continuing basis with the provisions of Section 274 of the Income Tax Act 2007.

The unaudited net asset value per ordinary share as at 31 December 2023 was 59.4 pence (30 September 2023 (unaudited) 58.6 pence).

The net asset value is stated before deducting the interim dividend of 1.8 pence per share in respect of the year ending 31 March 2024, which was paid to eligible shareholders on 17 January 2024.

For the purposes of calculating the net asset value per share, quoted investments are carried at bid price as at 31 December 2023 and unquoted investments are carried at fair value as at 31 December 2023 as determined by the directors.

New Investments:During the three months ended 31 December 2023 two new venture capital investments were completed.

Name of companyBusiness activityAmount invested£000
Wobble Genomics LimitedDevelopment of processes to extract, sequence and identify long-read RNA circulating in blood1,034
iOpt LimitedRemote performance monitoring of property assets for social housing sector1,006

In addition to the new investments above £2,055,000 was invested in four existing portfolio companies during the quarter.

Realisations:During the three months ended 31 December 2023 two venture capital investments were realised.

Name of companySale proceeds£000Original cost£000Carrying value at 30 September 2023£000
Haystack Dryers Limited2491,497218
Medovate Limited821,61182

The number of ordinary shares in issue at 31 December 2023 was 208,898,753. During the three months ended 31 December 2023 15,720,030 shares were allotted at prices between 59.80 pence per share and 63.02 pence per share and 1,264,397 shares were re-purchased for cancellation at a price of 55.67 pence per share.

Enquiries:

James Sly, Mercia Asset Management PLC – 0330 223 1430

Website: www.mercia.co.uk/vcts

The contents of the Mercia Asset Management PLC website and the contents of any website accessible from hyperlinks on the Mercia Asset Management PLC website (or any other website), are not incorporated into, nor forms part of, this announcement.

Date   Source Headline
4th Apr 20248:00 amGNWIssue of Equity and Total Voting Rights
28th Mar 202411:00 amGNWTotal voting rights
21st Mar 20243:00 pmGNWTransaction in Own Shares
8th Mar 20242:00 pmGNWOffer Update
6th Mar 20244:30 pmGNWTransaction in Own Shares
5th Mar 20243:31 pmGNWDirector Declaration
29th Feb 202411:00 amGNWTotal voting rights
9th Feb 20248:00 amGNWNet Asset Value
31st Jan 202411:00 amGNWTotal voting rights
17th Jan 20248:30 amGNWDirector/PDMR Shareholding
17th Jan 20248:00 amGNWIssue of Equity and Total Voting Rights
29th Dec 202311:00 amGNWTotal voting rights
20th Dec 20238:00 amGNWOffer Update - Utilisation of Over-Allotment Facility
7th Dec 202311:00 amGNWDirector/PDMR Shareholding
7th Dec 202311:00 amGNWDirector/PDMR Shareholding
7th Dec 202311:00 amGNWDirector/PDMR Shareholding
7th Dec 202310:00 amGNWIssue of Equity and Total Voting Rights
5th Dec 20234:15 pmGNWTransaction in Own Shares
30th Nov 202311:00 amGNWTotal voting rights
23rd Nov 20232:02 pmGNWDividend Declaration
23rd Nov 20232:01 pmGNWHalf-yearly report
23rd Nov 20232:00 pmGNWUnaudited Half-Yearly Financial Report for the Six Months Ended 30 September 2023
13th Nov 202310:00 amGNWStatement re change in registrar
31st Oct 202311:00 amGNWTotal voting rights
29th Sep 20239:00 amGNWTotal voting rights
27th Sep 20234:00 pmGNWTransaction in Own Shares
27th Sep 20238:00 amGNWOffer for subscription
18th Sep 20231:00 pmGNWPublication of Prospectus
31st Aug 202311:00 amGNWTotal voting rights
18th Aug 202310:30 amGNWDirector/PDMR Shareholding
18th Aug 20238:00 amGNWIssue of Equity and Total Voting Rights
31st Jul 202311:00 amGNWTotal voting rights
28th Jul 20233:30 pmGNWNet Asset Value
28th Jul 20231:30 pmGNWResult of AGM
28th Jul 20231:30 pmGNWResult of General Meeting
14th Jul 20238:30 amGNWTransaction in Own Shares
30th Jun 202311:00 amGNWTotal voting rights
26th Jun 20233:31 pmGNWNotice of General Meeting
26th Jun 20233:30 pmGNWAnnual Report and Notice of AGM
15th Jun 20233:02 pmGNWStatement regarding intention to fund raise
15th Jun 20233:01 pmGNWDividend Declaration
15th Jun 20233:00 pmGNWAnnual Financial Report for the Year Ended 31 March 2023
31st May 202311:00 amGNWTotal voting rights
28th Apr 202311:00 amGNWTotal voting rights
4th Apr 20237:15 amGNWDirector/PDMR Shareholding
4th Apr 20237:15 amGNWDirector/PDMR Shareholding
4th Apr 20237:15 amGNWDirector/PDMR Shareholding
4th Apr 20237:15 amGNWDirector/PDMR Shareholding
4th Apr 20237:00 amGNWIssue of Equity and Total Voting Rights
31st Mar 202311:00 amGNWTotal voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.